Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Main toxicity of anthracyclines |
|
Definition
Cardiotoxicity
because of reactive O2 species |
|
|
Term
| What happens to Irinotecan if you have up-regulation of UDP? |
|
Definition
Less irinotecan
(UDP for metabolism) |
|
|
Term
|
Definition
|
|
Term
| Advantage of liposomal Doxorubicin |
|
Definition
- Longer half life
- more drug in tumorĀ
|
|
|
Term
| How does Idarubicin differ? |
|
Definition
|
|
Term
|
Definition
- Metal binding domain
- chelate Fe
- (won't bind topo 2)
|
|
|
Term
|
Definition
|
|
Term
| Enzyme that inactivates Bleomycin |
|
Definition
|
|
Term
| Enzyme that activates Irinotecan |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Target DNA-protein complex |
|
|
Term
| Are anthracyclines cell cycle specific? |
|
Definition
|
|
Term
| Anthracycline active metabolite |
|
Definition
|
|